Major financial support awarded by Genome Quebec L’Institut de recherche clinique de Montreal
March 9, 2026
Genome Québec Supports a Research Team led by Dr. Éric Lécuyer to Develop a New Generation of Circular RNA–Based Therapies.
The initiative is conducted in collaboration with Sidong Huang and Mathieu Blanchette from McGill University, along with industrial partner RNA Technologies & Therapeutics (RNA T&T).
The project, which is funded through a proof of concept program, aims to develop an innovative platform for the design of circular RNAs (circRNAs) capable of targeting RNA binding proteins involved in the progression of certain cancers, including breast cancer.
